InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

- Current share price for IBX : $0.005

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Notification regarding unquoted securities - IBX 15 Jul 2025 4:50PM $0.017 $0.005 fallen by 70.59%
$4 Imagion MagSense Breast Cancer Program Phase 2 Trial Update 15 Jul 2025 9:26AM $0.014 $0.005 fallen by 64.29%
$4 Notification regarding unquoted securities - IBX 11 Jul 2025 4:44PM $0.016 $0.005 fallen by 68.75%
$4 Imagion Receive Positive FDA Feedback for HER2 Phase 2 Trial 10 Jul 2025 9:33AM $0.013 $0.005 fallen by 60%
$4 Landmark Venture Forum Presentation 12 Jun 2025 10:14AM $0.011 $0.005 fallen by 54.55%
$4 Change of Registered Office and Place of Business Address 2 Jun 2025 10:14AM $0.012 $0.005 fallen by 58.33%
$4 Results of 2025 AGM 30 May 2025 3:31PM $0.013 $0.005 fallen by 60%
$4 IBX AGM Business Update 29 May 2025 8:57AM $0.011 $0.005 fallen by 54.55%
$4 Notice of Annual General Meeting/Proxy Form 1 May 2025 10:36AM $0.013 $0.005 fallen by 61.54%
$4 Appendix 4C and Quarterly Activities Report - March 2025 30 Apr 2025 1:50PM $0.014 $0.005 fallen by 64.29%
$4 Application for quotation of securities - IBX 7 Apr 2025 4:18PM $0.014 $0.005 fallen by 64.29%
$4 Option Exp 13 Dec 2027 Range of Units and Top 20 Holders 7 Apr 2025 9:37AM $0.014 $0.005 fallen by 64.29%
$4 Application for quotation of securities - IBX 7 Apr 2025 9:31AM $0.014 $0.005 fallen by 64.29%
$4 Cleansing Prospectus - Placement Options 3 Apr 2025 3:27PM $0.017 $0.005 fallen by 70.59%
$4 Date of AGM and Closing Date for Director Nominations 1 Apr 2025 10:37AM $0.016 $0.005 fallen by 68.75%
$4 Updated Investor Presentation 27 Mar 2025 9:56AM $0.017 $0.005 fallen by 70.59%
$4 Appendix 4G and Corporate Governance Statement 24 Mar 2025 10:11AM $0.018 $0.005 fallen by 72.22%
$4 2024 Annual Report 24 Mar 2025 10:08AM $0.018 $0.005 fallen by 72.22%
$4 Appendix 4E and 2024 Financial Report 28 Feb 2025 3:11PM $0.018 $0.005 fallen by 71.43%
$4 Imagion Initiates Manufacturing of Drug for Phase 2 Study 19 Feb 2025 8:19AM $0.018 $0.005 fallen by 72.22%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2025 8:59AM $0.018 $0.005 fallen by 72.22%
$4 Corporate Year-End Update 17 Dec 2024 10:50AM $0.023 $0.005 fallen by 78.26%
$4 Update - Notification regarding unquoted securities - IBX 13 Dec 2024 4:50PM $0.024 $0.005 fallen by 79.17%
$4 Change of Director's Interest Notice (RP) 13 Dec 2024 11:24AM $0.026 $0.005 fallen by 80.77%
$4 Change of Director's Interest Notice (BM) 13 Dec 2024 11:21AM $0.026 $0.005 fallen by 80.77%

101 - 125 of 693 results

Page 5 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.